These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 17706529

  • 21. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
    Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B.
    Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
    [Abstract] [Full Text] [Related]

  • 22. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
    Zhao TT, Li JG, Li YM.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
    [Abstract] [Full Text] [Related]

  • 23. (18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors.
    Wang CL, Eissa MJ, Rogers JV, Aravkin AY, Porter BA, Beatty JD.
    AJR Am J Roentgenol; 2013 May; 200(5):1138-44. PubMed ID: 23617501
    [Abstract] [Full Text] [Related]

  • 24. [Diagnosis of breast carcinoma and locoregional lymph nodes with positron emission tomography].
    Avril N, Dose J, Ziegler S, Jänicke F, Schwaiger M.
    Radiologe; 1997 Sep; 37(9):741-8. PubMed ID: 9424620
    [Abstract] [Full Text] [Related]

  • 25. Overview of the current status of PET in breast cancer imaging.
    Wahl RL.
    Q J Nucl Med; 1998 Mar; 42(1):1-7. PubMed ID: 9646639
    [Abstract] [Full Text] [Related]

  • 26. Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors.
    Takabatake D, Taira N, Aogi K, Ohsumi S, Takashima S, Inoue T, Nishimura R.
    Breast Cancer; 2008 Mar; 15(2):181-4. PubMed ID: 18274836
    [Abstract] [Full Text] [Related]

  • 27. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Mar; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Indications for the use of PET or PET/CT in patients with breast cancer].
    Bernsdorf M, Graff J.
    Ugeskr Laeger; 2011 Oct 17; 173(42):2638-41. PubMed ID: 22027163
    [Abstract] [Full Text] [Related]

  • 32. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K.
    Cancer; 2002 Feb 15; 94(4):921-8. PubMed ID: 11920459
    [Abstract] [Full Text] [Related]

  • 33. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, Cortese AA, Hayes CE, Moe RE.
    Radiology; 1999 Mar 15; 210(3):807-14. PubMed ID: 10207485
    [Abstract] [Full Text] [Related]

  • 34. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
    Yanai A, Itoh M, Hirakawa H, Yanai K, Tashiro M, Harada R, Yoshikawa A, Yamamoto S, Ohuchi N, Ishida T.
    Tohoku J Exp Med; 2018 May 15; 245(1):13-19. PubMed ID: 29731479
    [Abstract] [Full Text] [Related]

  • 35. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
    Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R.
    Ann Surg Oncol; 2006 Mar 15; 13(3):397-404. PubMed ID: 16485158
    [Abstract] [Full Text] [Related]

  • 36. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Mar 15; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 37. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.
    Acta Radiol; 2015 Aug 15; 56(8):917-23. PubMed ID: 25013091
    [Abstract] [Full Text] [Related]

  • 38. 18-FDG imaging in breast cancer.
    Hoh CK, Schiepers C.
    Semin Nucl Med; 1999 Jan 15; 29(1):49-56. PubMed ID: 9990683
    [Abstract] [Full Text] [Related]

  • 39. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul 15; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 40. Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.
    Crowe JP, Adler LP, Shenk RR, Sunshine J.
    Ann Surg Oncol; 1994 Mar 15; 1(2):132-40. PubMed ID: 7834438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.